Twit­ter dis­ar­ray con­tin­ues as phar­ma ad­ver­tis­ers ex­tend paus­es and look around for op­tions, but keep tweet­ing

Phar­ma ad­ver­tis­ers on Twit­ter are done — at least for now. Ad spend­ing among the pre­vi­ous top spenders flat­tened even fur­ther last week, ac­cord­ing to the lat­est da­ta from ad track­er Path­mat­ics, amid on­go­ing tur­moil af­ter bil­lion­aire boss Elon Musk’s takeover now one month ago.

Among 18 top ad­ver­tis­ers tracked for End­points News, on­ly two are spend­ing: GSK and Bay­er. GSK spend­ing for the full week through Sun­day was min­i­mal at just un­der $1,900. Mean­while, Ger­man drug­mak­er Bay­er re­mains the in­dus­try out­lier up­ping its spend­ing to $499,000 last week from $480,000 the pre­vi­ous week. Bay­er’s spend­ing al­so marks a big in­crease from a month ago and be­fore the Musk takeover, when it spent $16,000 per week.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN